Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$44 Hold
4
﹤0.01% 742
2022
Q1
$34 Hold
4
﹤0.01% 1006
2021
Q4
$56 Hold
4
﹤0.01% 869
2021
Q3
$70 Sell
4
-9,280
-100% -$228K ﹤0.01% 1029
2021
Q2
$311K Sell
9,284
-3,490
-27% -$123K 0.07% 279
2021
Q1
$487K Buy
12,774
+4,930
+63% +$210K 0.14% 151
2020
Q4
$269K Sell
7,844
-11,373
-59% -$417K 0.08% 261
2020
Q3
$624K Sell
19,217
-2,090
-10% -$83.1K 0.18% 113
2020
Q2
$819K Buy
21,307
+13,666
+179% +$429K 0.22% 96
2020
Q1
$213K Buy
7,641
+1,127
+17% +$35.5K 0.06% 192
2019
Q4
$234K Sell
6,514
-2,752
-30% -$109K 0.04% 231
2019
Q3
$395K Buy
+9,266
New +$440K 0.07% 178

Other funds holding BZUN

Exane Derivatives's BZUN Position: Q2 2022 in Review

Exane Derivatives held its Baozun (BZUN) position steady in Q2 2022 at 4 shares worth $44. The position accounts for ﹤0.01% of the portfolio, ranked #742.

Exane Derivatives first reported a position in BZUN in Q3 2019 and has held it in 12 quarters since. The position peaked at $819K in Q2 2020. 103 funds tracked by Wall St. Rank hold BZUN as of Q2 2022.

  • Exane Derivatives held 4 shares of Baozun worth $44 as of Q2 2022.
  • Exane Derivatives left its Baozun share count unchanged in Q2 2022.
  • Baozun made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #742 holding.
  • Exane Derivatives first reported a position in Baozun in Q3 2019 and has held it in 12 quarters since.
  • Exane Derivatives's Baozun position peaked at $819K in Q2 2020.
  • 103 funds tracked by Wall St. Rank held Baozun as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.